Featured Research

from universities, journals, and other organizations

Penn Study Shows Genes May Affect Response To Different Quit-smoking Medications

Date:
August 30, 2005
Source:
University of Pennsylvania School of Medicine
Summary:
A study by researchers at the Transdisciplinary Tobacco Use Research Center (TTURC) of the University of Pennsylvania School of Medicine indicates that a smoker's genetic make-up may affect whether they quit or not while using either bupropion (Zyban©) or nicotine replacement therapies (NRTs) such as the nicotine patch or nasal spray.

Philadelphia, PA -- A study by researchers at the TransdisciplinaryTobacco Use Research Center (TTURC) of the University of PennsylvaniaSchool of Medicine indicates that a smoker's genetic make-up may affectwhether they quit or not while using either bupropion (Zyban) ornicotine replacement therapies (NRTs) such as the nicotine patch ornasal spray. The results appear in the August issue ofNeuropsychopharmacology.

"This study provides new evidence thatgenetic differences in the brain-reward pathways of smokers may revealwhether they would benefit more from Zyban© or nicotine replacementtherapy as an aid to quitting smoking," said lead author ProfessorCaryn Lerman, PhD, Director of the TTURC and Associate Director forCancer Control Population Sciences at Penn's Abramson Cancer Center.

Lermanled a research team that completed two randomized clinical trials eachwith a six-month follow-up period: a double blind placebo-controlledtrial of bupropion and an open-label trial of transdermal nicotinepatch versus nicotine nasal spray. Both trials examined the roles offunctional genetic variation in the dopamine D2 Receptor (DRD2) genecalled DRD2 –141C. At this location in the DRD2 gene, people carry oneof two different variants, a Del C variant or an Ins C variant (Del isfor deletion and Ins is for Insertion). The research team found thatsmokers with two copies of the DRD2 -141 Ins C variant weresignificantly more likely to be abstinent at the six-month follow-up ifthey used

Zyban©, as compared to smokers carrying the Del Cvariant. By contrast, smokers carrying the Del C variant hadsignificantly higher quit rates if they used NRTs as compared to thosewith the Ins C variant. This research may have important implicationsfor the delivery of quit-smoking medications that are targeted toindividual smokers' needs. "Although these results require confirmationin a larger study prior to translation to practice," said Lerman, "theydo suggest that genetic information may be useful in selecting the typeof nicotine dependence treatment that will be most beneficial for aparticular smoker."

###

This research was funded by theNational Cancer Institute and the National Institute on Drug Abuse andwas conducted by the University of Pennsylvania TransdisciplinaryTobacco Use Research Center.

About the Abramson Cancer Center:
The Abramson Cancer Center of the University of Pennsylvania wasestablished in 1973 as a center of excellence in cancer research,patient care, education and outreach. Today, the Abramson Cancer Centerranks as one of the nation's best in cancer care, according to U.S.News and World Report, and is one of the top five in National CancerInstitute (NCI) funding. It is one of only 39 NCI-designatedcomprehensive cancer centers in the United States. Home to one of thelargest clinical and research programs in the world, the AbramsonCancer Center of the University of Pennsylvania has 275 active cancerresearchers and 250 Penn physicians involved in cancer prevention,diagnosis and treatment. More information about the Abramson CancerCenter is available at: www.pennhealth.com/cancer


Story Source:

The above story is based on materials provided by University of Pennsylvania School of Medicine. Note: Materials may be edited for content and length.


Cite This Page:

University of Pennsylvania School of Medicine. "Penn Study Shows Genes May Affect Response To Different Quit-smoking Medications." ScienceDaily. ScienceDaily, 30 August 2005. <www.sciencedaily.com/releases/2005/08/050830065415.htm>.
University of Pennsylvania School of Medicine. (2005, August 30). Penn Study Shows Genes May Affect Response To Different Quit-smoking Medications. ScienceDaily. Retrieved September 17, 2014 from www.sciencedaily.com/releases/2005/08/050830065415.htm
University of Pennsylvania School of Medicine. "Penn Study Shows Genes May Affect Response To Different Quit-smoking Medications." ScienceDaily. www.sciencedaily.com/releases/2005/08/050830065415.htm (accessed September 17, 2014).

Share This



More Health & Medicine News

Wednesday, September 17, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

President To Send 3,000 Military Personnel To Fight Ebola

President To Send 3,000 Military Personnel To Fight Ebola

Newsy (Sep. 16, 2014) — President Obama is expected to send 3,000 troops to West Africa as part of the effort to contain Ebola's spread. Video provided by Newsy
Powered by NewsLook.com
Obama Orders Military Response to Ebola

Obama Orders Military Response to Ebola

AP (Sep. 16, 2014) — Calling the Ebola outbreak in West Africa a potential threat to global security, President Barack Obama is ordering 3,000 U.S. military personnel to the stricken region amid worries that the outbreak is spiraling out of control. (Sept. 16) Video provided by AP
Powered by NewsLook.com
UN: 20,000 Could Be Infected With Ebola by Year End

UN: 20,000 Could Be Infected With Ebola by Year End

AFP (Sep. 16, 2014) — Nearly $1.0 billion dollars is needed to fight the Ebola outbreak raging in west Africa, the United Nations say, warning that 20,000 could be infected by year end. Duration: 00:40 Video provided by AFP
Powered by NewsLook.com
Obama: Ebola Outbreak Threat to Global Security

Obama: Ebola Outbreak Threat to Global Security

AP (Sep. 16, 2014) — President Obama is ordering U.S. military personnel to West Africa to deal with the Ebola outbreak, which is he calls a potential threat to global security. (Sept. 16) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

    Technology News



    Save/Print:
    Share:  

    Free Subscriptions


    Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

    Get Social & Mobile


    Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

    Have Feedback?


    Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
    Mobile iPhone Android Web
    Follow Facebook Twitter Google+
    Subscribe RSS Feeds Email Newsletters
    Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins